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According to current European classification, cardiomy-
opathies are defined as myocardial disorders that cannot be
explained by coronary artery disease or abnormal loading
conditions including valvular and congenital diseases. Six
specific morphological and functional phenotypes are dis-
tinguished: hypertrophic, dilated, restrictive, and arrhyth-
mogenic right ventricular cardiomyopathy together with
two unclassified subtypes: Tako-tsubo and left ventricular
noncompaction cardiomyopathies. In almost all of these phe-
notypes, inherited forms may be found; moreover, in some
of them—for example, in hypertrophic cardiomyopathy—a
genetic origin is even a rule. Therefore, genetic counseling
shall be an integral part of the state-of-the-art care of
patients with heart muscle disorders.The affected individuals
together with their relatives have to be informed about the
genetic basis of their disease and the potential risk for other
family members. A detailed cardiac evaluation, including
ECG and echocardiography (in some cases also Holter ECG
monitoring), of first-degree relatives is necessary with their
further regular follow-up. If available, genetic testing shall
be discussed with the patients as it may improve their
management as well as enable effective preventive genetic
testing in other relatives.
Because the evaluation of morphology and function of
the heart, especially of the left ventricle, is a prerequisite
for accurate phenotypic characterization of every myocar-
dial disease, a multimodality imaging approach generally
becomes necessary. Echocardiography is still a cornerstone
of diagnostic imaging because it is accurate, widely available,
safe, and without any contraindications. In recent years,
advanced echo modalities gained a clinical role in the follow-
up of chemotherapy-induced cardiomyopathy, and global
longitudinal strain is recommended in the latest European
guidelines.
However, the role of cardiac magnetic resonance is
increasingly important. Not only is it the current gold stan-
dard for morphological and functional assessment of heart
chambers, but it has a unique opportunity of noninvasive
tissue characterization. Based on evaluation of the presence of
myocardial edema, hyperemia, and necrosis using dedicated
sequences, cardiac magnetic resonance is capable of diagnos-
ing acute myocarditis with high accuracy. Late gadolinium
enhancement technique is widely used to assess the presence
and extent of replacement myocardial fibrosis, which appears
to be strongly related to the prognosis of affected individuals.
Presence of myocardial fibrosis predisposes to increased risk
of ventricular arrhythmias, sudden cardiac death, and pro-
gression of left ventricular dysfunction associated with heart
failure worsening. One also has to mention the significant
contribution of various techniques of nuclear medicine for
the diagnosis of cardiac sarcoidosis and transthyretin amyloid
cardiomyopathy.
It is obvious that increasing knowledge on ethiopathogen-
esis of various myocardial disorders together with improved
diagnostic possibilities shall result in novel therapeutic
options. A complex immunohistochemical and PCR analysis
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of endomyocardial biopsy specimens allows us to charac-
terize in more detail the presence and type of myocardial
inflammation as well as the presence of possible causative
infectious agents and select better more targeted treatment
of acute myocarditis and inflammatory cardiomyopathy with
administration of immunosuppressive or immunomodula-
tory drugs or antiviral agents. Many therapeutic strategies are
currently investigated in the field of transthyretin amyloidosis
including stabilizers of transthyretin tetramers and gene
therapies aimed at suppression of transthyretin expression.
Another important topic is the development of new treatment
possibilities that will be able to prevent late sequelae of
cytostatic therapy associatedwith potential cardiotoxic effect.
In this special issue we are pleased to introduce several
interesting original as well as review articles focused on
different topics in the field of myocardial diseases.
(i) Two original articles deal with the topic of chemo-
therapy-induced cardiotoxicity. P. Robinson et al.
investigated in their experimental study the role of
substance P in chemotherapy-associated death of car-
diomyocytes and chemoresistance and nicely showed
that aprepitant, a substance P receptor antagonist,
is able to decrease doxorubicin induced death of
cardiomyocytes as well as to increase the sensitivity of
cancer cells to this drug. A. F. Yu et al. evaluated the
use of 2D speckle tracking echocardiography in early
diagnosis of cardiotoxicity associated with anthracy-
clines and radiation therapy. Their results confirm
that this novel imaging modality is more sensitive
in detecting left ventricular systolic dysfunction than
traditional indices of ventricular function such as
ejection fraction and thus can be used for long-term
cardiac surveillance of adult cancer survivors.
(ii) Three articles review several aspects of inflamma-
tion/infection related myocardial diseases. J. Krejci
et al. largely summarize our current knowledge on
pathophysiology, diagnosis, and treatment of inflam-
matory cardiomyopathy with emphasis on accurate
evaluation of endomyocardial biopsy samples, which
is prerequisite for the appropriate choice of subse-
quent treatment options. P. Kuchynka et al. nicely
overview a difficult topic of eosinophilic myocarditis,
a rare disorder necessitating quite rapid diagnosis, so
early administration of immunosuppressive therapy
that may improve the poor prognosis of affected
individuals can be initiated. In the last article, R.
H. Lumsden and G. S. Bloomfield present a brilliant
review on HIV-associated cardiomyopathy which
currently represents a significant cause of morbidity
andmortality in this now chronic disease.The authors
clearly demonstrate that there is a significant need
to design clear guidelines for screening protocols
and diagnostic criteria for HIV-related myocardial
disease.
(iii) Several issues related to hypertrophic cardiomyopa-
thy are discussed in three articles. R. Pudil et al. aimed
to investigate the significance of vascular endothelial
growth factor in hypertrophic cardiomyopathy and
their results show that increased levels of this sub-
stance are associated with structural and functional
parameters in patients with hypertrophic cardiomy-
opathy suggesting the possibility of its use for a more
accurate diagnosis. L. K. Williams et al. focused on
left atrial function in hypertrophic cardiomyopathy.
Using magnetic resonance velocity vector imaging,
they convincingly demonstrate a negative impact of
left ventricular outflow tract obstruction on left atrial
size and function that significantly improves after
septalmyectomy. Finally, P. P.Dimitrow andR.Rajtar-
Salwa review several aspects related to left ventricular
outflow tract obstruction with emphasis on invasive
as well as noninvasive treatment possibilities.
If the readers will find the presented articles informative
and stimulating their interest in myocardial disorders, the
purpose of this special issue will be completely fulfilled.
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